| Year |
Citation |
Score |
| 2023 |
Kochoian BA, Bure C, Papa SM. Targeting Striatal Glutamate and Phosphodiesterases to Control L-DOPA-Induced Dyskinesia. Cells. 12. PMID 38067182 DOI: 10.3390/cells12232754 |
0.557 |
|
| 2022 |
Masilamoni GJ, Sinon CG, Kochoian BA, Singh A, McRiner AJ, Leventhal L, Papa SM. Phosphodiesterase 9 inhibition prolongs the antiparkinsonian action of l-DOPA in parkinsonian non-human primates. Neuropharmacology. 212: 109060. PMID 35461880 DOI: 10.1016/j.neuropharm.2022.109060 |
0.554 |
|
| 2021 |
Bohnen NI, Costa RM, Dauer WT, Factor SA, Giladi N, Hallett M, Lewis SJG, Nieuwboer A, Nutt JG, Takakusaki K, Kang UJ, Przedborski S, Papa SM. Discussion of Research Priorities for Gait Disorders in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34939221 DOI: 10.1002/mds.28883 |
0.306 |
|
| 2021 |
Masilamoni GJ, Weinkle A, Papa SM, Smith Y. Cortical Serotonergic and Catecholaminergic Denervation in MPTP-Treated Parkinsonian Monkeys. Cerebral Cortex (New York, N.Y. : 1991). PMID 34519330 DOI: 10.1093/cercor/bhab313 |
0.354 |
|
| 2021 |
Barbuti PA, Barker RA, Brundin P, Przedborski S, Papa SM, Kalia LV, Mochizuki H. Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33963552 DOI: 10.1002/mds.28628 |
0.385 |
|
| 2021 |
Beck G, Zhang J, Fong K, Mochizuki H, Maral Mouradian M, Papa SM. Striatal ΔFosB gene suppression inhibits the development of abnormal involuntary movements induced by L-Dopa in rats. Gene Therapy. PMID 33707771 DOI: 10.1038/s41434-021-00249-7 |
0.546 |
|
| 2020 |
Singh A, Papa SM. Striatal oscillations in parkinsonian non-human primates. Neuroscience. PMID 32905842 DOI: 10.1016/J.Neuroscience.2020.09.004 |
0.328 |
|
| 2020 |
Dyavar SR, Potts LF, Beck G, Shetty BLD, Lawson B, Podany AT, Fletcher CV, Amara RR, Papa SM. Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L-Dopa-induced dyskinesia in parkinsonian rats. Genes, Brain, and Behavior. PMID 32741046 DOI: 10.1111/gbb.12690 |
0.32 |
|
| 2019 |
Beck G, Singh A, Zhang J, Potts LF, Woo JM, Park ES, Mochizuki H, Mouradian MM, Papa SM. Role of striatal ΔFosB in l-Dopa-induced dyskinesias of parkinsonian nonhuman primates. Proceedings of the National Academy of Sciences of the United States of America. PMID 31455727 DOI: 10.1073/pnas.1907810116 |
0.634 |
|
| 2019 |
de Iure A, Napolitano F, Beck G, Quiroga Varela A, Durante V, Sciaccaluga M, Mazzocchetti P, Megaro A, Tantucci M, Cardinale A, Punzo D, Mancini A, Costa C, Ghiglieri V, Tozzi A, ... ... Papa SM, et al. Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30759320 DOI: 10.1002/mds.27632 |
0.325 |
|
| 2018 |
Zheng C, Chen G, Tan Y, Zeng W, Peng Q, Wang J, Cheng C, Yang X, Nie S, Xu Y, Zhang Z, Papa SM, Ye K, Cao X. TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone. Frontiers in Cellular Neuroscience. 12: 485. PMID 30618632 DOI: 10.3389/fncel.2018.00485 |
0.347 |
|
| 2018 |
Zheng C, Chen G, Tan Y, Zeng W, Peng Q, Wang J, Cheng C, Yang X, Nie S, Xu Y, Zhang Z, Papa SM, Ye K, Cao X. TRH Analog, Taltirelin Improves Motor Function of Hemi-PD Rats Without Inducing Dyskinesia via Sustained Dopamine Stimulating Effect. Frontiers in Cellular Neuroscience. 12: 417. PMID 30555300 DOI: 10.3389/fncel.2018.00417 |
0.496 |
|
| 2018 |
Beck G, Maehara S, Chang PL, Papa SM. A selective phosphodiesterase 10A inhibitor reduces l-dopa-induced dyskinesias in parkinsonian monkeys. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29508924 DOI: 10.1002/mds.27341 |
0.378 |
|
| 2018 |
Singh A, Jenkins MA, Burke KJ, Beck G, Jenkins A, Scimemi A, Traynelis SF, Papa SM. Glutamatergic Tuning of Hyperactive Striatal Projection Neurons Controls the Motor Response to Dopamine Replacement in Parkinsonian Primates. Cell Reports. 22: 941-952. PMID 29386136 DOI: 10.1016/J.Celrep.2017.12.095 |
0.709 |
|
| 2017 |
Beck G, Singh A, Papa SM. Dysregulation of striatal projection neurons in Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 28620834 DOI: 10.1007/S00702-017-1744-5 |
0.478 |
|
| 2017 |
Chen G, Nie S, Han C, Ma K, Xu Y, Zhang Z, Papa SM, Cao X. Antidyskinetic Effects of MEK Inhibitor Are Associated with Multiple Neurochemical Alterations in the Striatum of Hemiparkinsonian Rats. Frontiers in Neuroscience. 11: 112. PMID 28337120 DOI: 10.3389/fnins.2017.00112 |
0.457 |
|
| 2016 |
Han C, Nie S, Chen G, Ma K, Xiong N, Zhang Z, Xu Y, Wang T, Papa SM, Cao X. Intrastriatal injection of ionomycin profoundly changes motor response to L-DOPA and its underlying molecular mechanisms. Neuroscience. PMID 27771532 DOI: 10.1016/j.neuroscience.2016.10.033 |
0.52 |
|
| 2016 |
Masilamoni GJ, Uthayathas S, Koenig G, Leventhal L, Papa SM. Effects of a novel phosphodiesterase 10A inhibitor in non-human primates: A therapeutic approach for schizophrenia with improved side effect profile. Neuropharmacology. PMID 27539962 DOI: 10.1016/j.neuropharm.2016.08.012 |
0.318 |
|
| 2016 |
Singh A, Mewes K, Gross RE, DeLong MR, Obeso JA, Papa SM. Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 113: 9629-34. PMID 27503874 DOI: 10.1073/Pnas.1606792113 |
0.376 |
|
| 2015 |
Potts LF, Park ES, Woo JM, Dyavar Shetty BL, Singh A, Braithwaite SP, Voronkov M, Papa SM, Mouradian MM. Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease. Annals of Neurology. 77: 930-41. PMID 25820831 DOI: 10.1002/Ana.24375 |
0.407 |
|
| 2015 |
Du H, Nie S, Chen G, Ma K, Xu Y, Zhang Z, Papa SM, Cao X. Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum. Parkinson's Disease. 2015: 253878. PMID 25692070 DOI: 10.1155/2015/253878 |
0.481 |
|
| 2015 |
Singh A, Liang L, Kaneoke Y, Cao X, Papa SM. Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates. Journal of Neurophysiology. 113: 1533-44. PMID 25505120 DOI: 10.1152/Jn.00910.2014 |
0.485 |
|
| 2014 |
Uthayathas S, Masilamoni GJ, Shaffer CL, Schmidt CJ, Menniti FS, Papa SM. Phosphodiesterase 10A inhibitor MP-10 effects in primates: comparison with risperidone and mechanistic implications. Neuropharmacology. 77: 257-67. PMID 24490227 DOI: 10.1016/j.neuropharm.2013.10.015 |
0.359 |
|
| 2014 |
Potts LF, Wu H, Singh A, Marcilla I, Luquin MR, Papa SM. Modeling Parkinson's disease in monkeys for translational studies, a critical analysis. Experimental Neurology. 256: 133-43. PMID 24070854 DOI: 10.1016/J.Expneurol.2013.09.014 |
0.343 |
|
| 2012 |
Revuelta GJ, Uthayathas S, Wahlquist AE, Factor SA, Papa SM. Non-human primate FOG develops with advanced parkinsonism induced by MPTP Treatment. Experimental Neurology. 237: 464-9. PMID 22967858 DOI: 10.1016/j.expneurol.2012.07.021 |
0.351 |
|
| 2010 |
Cao X, Yasuda T, Uthayathas S, Watts RL, Mouradian MM, Mochizuki H, Papa SM. Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 7335-43. PMID 20505100 DOI: 10.1523/JNEUROSCI.0252-10.2010 |
0.405 |
|
| 2009 |
Xu Y, Zhang Z, Qin K, Papa SM, Cao X. Quantitative autoradiographic study on receptor regulation in the basal ganglia in rat model of levodopa-induced motor complications. Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban. 29: 156-62. PMID 19399396 DOI: 10.1007/s11596-009-0204-3 |
0.315 |
|
| 2008 |
Liang L, DeLong MR, Papa SM. Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7537-47. PMID 18650331 DOI: 10.1523/JNEUROSCI.1176-08.2008 |
0.374 |
|
| 2008 |
Papa SM. The cannabinoid system in Parkinson's disease: multiple targets to motor effects. Experimental Neurology. 211: 334-8. PMID 18433745 DOI: 10.1016/j.expneurol.2008.03.009 |
0.385 |
|
| 2007 |
Cao X, Liang L, Hadcock JR, Iredale PA, Griffith DA, Menniti FS, Factor S, Greenamyre JT, Papa SM. Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 323: 318-26. PMID 17630359 DOI: 10.1124/jpet.107.125666 |
0.554 |
|
| Show low-probability matches. |